Nautilus Biotechnology, Inc.
NAUTBiotechnology
$3.14−2.18%As of Oct 29vs prior close
- Market cap
- $399.9M
- P/E (TTM)
- –
- From 52W high
- −20.51%
- EPS (LTM)
- -$0.46
- Dividend yield
- 0.00%
Nomior Score
40
Steady ProfileBottom 30% of the scored universe
Growth61
Quality47
Value33
Momentum46
Resilience38
Connections
Revenue to profitQ3 YE26
The net loss was 6682% of revenue.
Who owns it
2funds